YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
* Can-Fite Biopharma press release [https://seekingalpha.com/pr/20642776-can-fite-reports-q2-2026-financial-results-and-ongoing-clinical-progress-highlighting-longer] (CANF [https://seekingalpha.com/symbol/CANF]): 1H GAAP EPS of -$1.24. *…
Can-Fite BioPharma Ltd. (NYSE:CANF) reported extended survival trends in a key late-stage cancer trial alongside a $4 million warrant exercise agreement to fund ongoing clinical operations. • Can Fite Biopharma stock is at significant supp…
Can-Fite BioPharma Ltd. RAMAT GAN, Israel, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF) ("Can-Fite" or the "Company"), a clinical-stage biotechnology company developing a pipeline of proprie…
[Forex colorful diagrams and stock market data with lines and dynamics] ismagilov Stock futures pointed lower on Thursday, putting Wall Street on track to end the holiday-shortened week on a softer note ahead of America's 250th Independenc…
(RTTNews) - Today's leading biotech gainers include Can-Fite, following an update from its pancreatic cancer study; SeaStar Medical, driven by improving quarter-over-quarter revenue for its flagship product; and Elicio, which has refined i…
* Can-Fite Biopharma press release [https://seekingalpha.com/pr/20452724-can-fite-reports-2025-financial-results-and-ongoing-clinical-progress-highlighting-positive] (CANF [https://seekingalpha.com/symbol/CANF]): FY GAAP EPS of -$5.97. * R…
Can-Fite BioPharma CANF shares soared 20.4% on Wednesday after the company reported positive top-line results from a mid-stage study of its investigational candidate, namodenoson, in patients with advanced pancreatic ductal adenocarcinoma…
With U.S. stock futures trading slightly lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: UiPath Inc.(NYSE:PATH) shares gained in extended trading on Tuesday after it was announced that…
RAMAT GAN, Israel, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs targeting oncological and inflammatory diseas…
* Can-Fite BioPharma’s (CANF [https://seekingalpha.com/symbol/CANF]) board approved a 1-for-3,000 reverse split [https://seekingalpha.com/pr/20348629-can-fite-announces-reverse-split-of-its-ordinary-shares-and-ads-ratio-change] of its ordi…
RAMAT GAN, Israel, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs targeting oncological and inflammatory diseas…
RAMAT GAN, Israel, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs targeting oncological and inflammatory diseas…
~35% of erectile dysfunction patients in a $3.2 billion market are non-responders to brands including Viagra and Cialis, and these drugs can be contraindicated for an estimated 16 million men living with diabetes CF602’s unique mechanism o…
Ramat Gan, Israel, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and inflammatory disea…
Primary endpoint is safety; Namodenoson continues to demonstrate a favorable safety profile Ramat Gan, Israel, July 30, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a clinical-stage biotechnology com…
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements. [topmovers] GAINERS TICKER CHANGE COMMENT CREV [https://www.chartmill.com/stock/quote/CREV/profile] 59.27% Exciting news for C…
$5.0 million upfront with up to an additional $10.0 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants RAMAT GAN, Israel, July 28, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American:…
Ramat Gan, Israel, July 28, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a clinical-stage biotechnology company developing a pipeline of proprietary small molecule drugs for the treatment of cancer a…
* Can-Fite BioPharma (NYSE:CANF [https://seekingalpha.com/symbol/CANF]) is offering up to 4.9 million ADSs (representing 1.47 billion ordinary shares) and 4.9 million common warrants in a best-efforts offering. * Each ADS will be sold with…
PETACH TIKVA, Israel, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory…
Shares of Minerva Neurosciences NERV were down 38.9% on Dec 28 after management announced that the FDA’s refuse-to-file letter on the company’s new drug application (“NDA”) filing was still in effect. The NDA filing sought approval for rol…
Pacira BioSciences, Inc. PCRX reported third-quarter 2022 adjusted earnings of 64 cents per share, missing the Zacks Consensus Estimate of 73 cents. The company reported adjusted earnings of 72 cents per share in the year-ago quarter. Tota…
Corcept Therapeutics Incorporated CORT reported earnings of 30 cents per share for third-quarter 2022, beating the Zacks Consensus Estimate of 23 cents. In the year-ago quarter, the company reported earnings of 24 cents per share. Revenues…
Can-Fite BioPharma CANF announced that it is filing new patent applications in multiple countries to treat all advanced solid tumors. The patents seek to cover Can-Fite’s growing IP portfolio, including the company’s A3 adenosine receptor…
Intra-Cellular Therapies, Inc.’s ITCI shares rose 15.8% after the company announced that its patented Caplyta was approved by the FDA for bipolar depression. Shares of Verso Corporation VRSjumped 34.9% after the company announced that it w…
PETACH TIKVA, Israel, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver…
Photo by Christina Victoria Craft on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Amgen Inc. (NASDAQ: AMGN) recently ann…
Below is a recap of the main news related to the cannabis industry and markets for the week of August 27, 2021. Contents The Votes At Tilray, KushCo, Greenlane New York Getting Greener Hexo’s Nasdaq Debut Markets M&A Financings Earnings Re…
Can-Fite BioPharma (NYSE: CANF) has initiated a series of preclinical studies required by regulators to support potential marketing registration filings for its drug candidates Piclidenoson and Namodenoson in the U.S. and Europe. As part o…
Moderna, Can-Fite BioPharma, New Fortress Energy, iHeartMedia and Fintech Acquisition V are five top stock gainers for Tuesday.
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 15) Aclaris Therapeutics, Inc. (NASDAQ: ACRS) Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) Amneal…
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 15) Aclaris Therapeutics, Inc. (NASDAQ: ACRS) Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) Amneal…
Pacira BioSciences, Inc. PCRX reported fourth-quarter 2020 earnings of 87 cents per share, beating the Zacks Consensus Estimate of 82 cents and also increasing from the year-ago earnings of 56 cents. Total revenues increased 7% to $131 mil…
Pacira BioSciences, Inc. PCRX reported fourth-quarter 2020 earnings of 87 cents per share, beating the Zacks Consensus Estimate of 82 cents and also increasing from the year-ago earnings of 56 cents. Total revenues increased 7% to $131 mil…
LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. Registration details and the company…
PETACH TIKVA, Israel, May 20, 2019 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd.(NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory d…